- Home
- PLX vs RPID Comparison
PLX vs RPID Comparison
Compare PLX & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- RPID
- Stock Information
- Founded
- PLX 1993
- RPID 2006
- Country
- PLX United States
- RPID United States
- Employees
- PLX N/A
- RPID N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- RPID Medical Specialities
- Sector
- PLX Health Care
- RPID Health Care
- Exchange
- PLX Nasdaq
- RPID Nasdaq
- Market Cap
- PLX 127.4M
- RPID 138.9M
- IPO Year
- PLX 1998
- RPID 2021
- Fundamental
- Price
- PLX $1.54
- RPID $3.40
- Analyst Decision
- PLX Strong Buy
- RPID Strong Buy
- Analyst Count
- PLX 1
- RPID 2
- Target Price
- PLX $15.00
- RPID $8.00
- AVG Volume (30 Days)
- PLX 498.6K
- RPID 99.3K
- Earning Date
- PLX 08-14-2025
- RPID 08-12-2025
- Dividend Yield
- PLX N/A
- RPID N/A
- EPS Growth
- PLX N/A
- RPID N/A
- EPS
- PLX 0.05
- RPID N/A
- Revenue
- PLX $59,764,000.00
- RPID $29,645,000.00
- Revenue This Year
- PLX $10.00
- RPID $17.94
- Revenue Next Year
- PLX $83.13
- RPID $20.55
- P/E Ratio
- PLX $32.18
- RPID N/A
- Revenue Growth
- PLX 0.18
- RPID 28.36
- 52 Week Low
- PLX $0.82
- RPID $0.75
- 52 Week High
- PLX $3.10
- RPID $4.50
- Technical
- Relative Strength Index (RSI)
- PLX 53.22
- RPID 46.32
- Support Level
- PLX $1.41
- RPID $3.21
- Resistance Level
- PLX $1.52
- RPID $3.68
- Average True Range (ATR)
- PLX 0.06
- RPID 0.36
- MACD
- PLX 0.01
- RPID -0.05
- Stochastic Oscillator
- PLX 56.52
- RPID 21.43
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.